Adicet Bio Q3 EPS $(0.53) Down From $(0.44) YoY

Adicet Bio (NASDAQ:ACET) reported quarterly losses of $(0.53) per share. This is a 20.45 percent decrease over losses of $(0.44) per share from the same period last year.

Adicet Bio (NASDAQ:ACET) reported quarterly losses of $(0.53) per share. This is a 20.45 percent decrease over losses of $(0.44) per share from the same period last year.

Total
0
Shares
Related Posts
Read More

Colgate-Palmolive Has Strong Brand-Building And Analytics-Driven Marketing Strategy, Says Analyst

BofA Securities analyst Bryan Spillane boosts Colgate-Palmolive's target to $100, citing impressive growth metrics. CL started the year strong with +9.8% organic sales and EPS of $0.86, beating estimates. Pricing surged +8.5%, driving a significant margin expansion. Hyperinflation in select regions fueled performance, while North America saw notable market share gains, a testament to Colgate's marketing prowess.

CL